On July 29th, 2019 at 16:38, Wang Wange of Workshop 209, on the second floor of Building Y53, was performing a TLC test on the cyclization reaction solution 3011-B2190751-HH of simvastatin 3011-B2190751-CP, and found that the sample climbing plate was abnormal After the simvastatin 3011-B2190751-CP batch climbing board developed color, the simvastatin point and the ammonium salt point were not completely separated, and the size of the ammonium salt point could not be determined. <br><br>The main reason for this deviation is that the operator did not check the console after the TLC board operation in the morning, and forgot to put the lid of the developing agent exhibition cylinder back, causing the developing agent in the exhibition cylinder to volatilize, thereby reducing the polarity of the developing agent. Eventually, the ammonium salt point and simvastatin in the sample could not be separated and did not meet the requirements. <br><br>This deviation belongs to the operator's forgetting to replace the cover of the exhibition cylinder during the TLC detection process, resulting in the evaporation agent in the exhibition cylinder evaporating. It belongs to the operation deviation of the personnel, and there is no problem with the sample itself. Replacing the developing agent in the exhibition tank, the TLC spotting was re-used at 16:49 on July 29, 2019. The ammonium salt content is less than 1%, which meets the process requirements and the next step can be performed. <br><br>1. The original test TLC spot board shall be invalid and retained, and the test result shall be retested as is and the test report shall be issued. <br>2. Mark on the cover of the exhibition tank (cover it in time), and use the deviation as an example to train the post operator, emphasizing that the operator should check the operation platform after the test and cover it in time.
正在翻译中..